Inhaled Corticosteroid Escalation After a Single Moderate Exacerbation in COPD : Differential Benefit by Exacerbation Subtype

Study limitation reported by the research below: “The study design is a target trial emulation using administrative claims data, not a randomized controlled trial—causal inference should be interpreted with caution.”